Company Introduction:

Guangzhou Jingyuan Pharmaceutical Research Co., Ltd. was established in 2012 and is the first CRO in South China to focus on clinical research data management, biostatistics, medical affairs, and drug vigilance services. Under its umbrella, Gu Kelin Technology Co., Ltd. specializes in the research and development services of clinical trial digital systems, independently developing systems such as EDC, CTMS+, PV, IRT, ePRO, SAP, Samplesize, etc. Over the past 11 years, Jingyuan Pharmaceutical has provided data management, statistical analysis, medical affairs, and drug vigilance services for over 600 sponsor/CRO/clinical research institutions and 2300+projects, involving clinical trials of chemical drugs, biological products, vaccines, traditional Chinese medicine Phase I-IV drugs, BE/PK trials, medical devices, in vitro diagnostic reagents, and more.